Vitamin D metabolism is changed and FGF23 levels are increased in patients with cirrhosis
Aktuelle Ernährungsmedizin · 01.05.2024 · 49 (03) · E21
DOI: 10.1055/s-0044-1785772 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aktuelle Ernährungsmedizin, erschienen am 01.05.2024. Verfasst von A. Nier und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Vitamin D (VD) deficiency, assessed by plasma 25-Hydroxyvitamin-D (25(OH)D), is highly prevalent in chronic liver disease (CLD) and associated with disease progression and complications. However, the variable response of individuals to VD supplementation indicates the limitation of 25(OH)D levels to provide insights into the metabolic situation, especially in severely ill patients. Therefore, the aim of the current project was to evaluate different VD metabolites and Fibroblast Growth Factor 23 (FGF23), a hormone that regulates the synthesis of the active VD metabolite calcitriol, in different stages of CLD.
Methods
Thirty-nine patients (74% male, mean age: 58 years) of the Jena University Hospital with decompensated liver cirrhosis as well as 88 participants of the prospective multicenter cohort study “German National Cohort (NAKO)” with hepatic steatosis (n=44) and controls without hepatic steatosis (n=44), matched in age, gender and season of blood collection, were included in the current analysis. 7-Dehydrocholesterol (7-DHC), VD3, 25(OH)D3 and 24,25-dihydroxyvitamin D3 (24,25(OH)2D3) plasma levels were analyzed using liquid chromatography-tandem mass spectrometry. Concentrations of calcitriol, VD-binding protein (DBP) and intact FGF23 (iFGF23) were determined in plasma by commercial ELISA kits.
Results
None of the parameters assessed differed between the two NAKO groups. In cirrhosis patients, plasma levels of 7-DHC (-45%), 25(OH)D3 (-70%) and DBP (-55%) were markedly reduced compared to controls and participants with steatosis (7-DHC: -50%, 25(OH)D3: -70%, DBP: -55%) (all p
Zitieren
APA
Nier, A., Kühn, J., Kluttig, A., Mikolajczyk, R., Weißenborn, C., Zipprich, A., Reuken, P., & Stangl, G. (2024). Vitamin D metabolism is changed and FGF23 levels are increased in patients with cirrhosis. Aktuelle Ernährungsmedizin, 49(03), E21. https://doi.org/10.1055/s-0044-1785772
Vancouver
Nier A, Kühn J, Kluttig A, Mikolajczyk R, Weißenborn C, Zipprich A, et al. Vitamin D metabolism is changed and FGF23 levels are increased in patients with cirrhosis. Aktuelle Ernährungsmedizin. 2024;49(03):E21. doi:10.1055/s-0044-1785772
BibTeX
@article{Nier2024,
author = {Nier, A. and Kühn, J. and Kluttig, A. and Mikolajczyk, R. and Weißenborn, C. and Zipprich, A. and Reuken, P. and Stangl, G.},
title = {Vitamin D metabolism is changed and FGF23 levels are increased in patients with cirrhosis},
journal = {Aktuelle Ernährungsmedizin},
year = {2024},
volume = {49},
number = {03},
pages = {E21},
doi = {10.1055/s-0044-1785772}
}
EUVIMED